全文获取类型
收费全文 | 716篇 |
免费 | 46篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 23篇 |
妇产科学 | 3篇 |
基础医学 | 71篇 |
口腔科学 | 13篇 |
临床医学 | 103篇 |
内科学 | 167篇 |
皮肤病学 | 14篇 |
神经病学 | 57篇 |
特种医学 | 152篇 |
外科学 | 20篇 |
综合类 | 16篇 |
预防医学 | 38篇 |
眼科学 | 1篇 |
药学 | 93篇 |
肿瘤学 | 35篇 |
出版年
2022年 | 7篇 |
2021年 | 6篇 |
2020年 | 2篇 |
2019年 | 7篇 |
2018年 | 3篇 |
2017年 | 2篇 |
2016年 | 9篇 |
2015年 | 15篇 |
2014年 | 8篇 |
2013年 | 15篇 |
2012年 | 19篇 |
2011年 | 15篇 |
2010年 | 15篇 |
2009年 | 14篇 |
2008年 | 22篇 |
2007年 | 49篇 |
2006年 | 16篇 |
2005年 | 25篇 |
2004年 | 12篇 |
2003年 | 18篇 |
2002年 | 19篇 |
2001年 | 15篇 |
2000年 | 23篇 |
1999年 | 22篇 |
1998年 | 32篇 |
1997年 | 33篇 |
1996年 | 30篇 |
1995年 | 30篇 |
1994年 | 22篇 |
1993年 | 27篇 |
1992年 | 24篇 |
1991年 | 16篇 |
1990年 | 23篇 |
1989年 | 20篇 |
1988年 | 26篇 |
1987年 | 15篇 |
1986年 | 15篇 |
1985年 | 23篇 |
1984年 | 13篇 |
1983年 | 18篇 |
1982年 | 12篇 |
1981年 | 12篇 |
1980年 | 12篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 14篇 |
1976年 | 9篇 |
1975年 | 4篇 |
1962年 | 1篇 |
1959年 | 1篇 |
排序方式: 共有808条查询结果,搜索用时 15 毫秒
711.
Leach KR; Kurisu Y; Carlson JE; Repa I; Epstein DH; Urness M; Sahatjian R; Hunter DW; Casteneda-Zuniga WR; Amplatz K 《Radiology》1990,175(3):675-677
The thrombogenicities of stainless steel spring guide wires and two hydrophilically coated guide wires were compared. The guide wires were placed in canine femoral arteries for 30 minutes. The guide wires were removed, the thrombi were stripped off, and the clots were weighed. Clot weights obtained with the two hydrophilically coated guide wires were significantly less than those obtained with the stainless steel spring guide wires. The thrombogenicities of hydrophilically coated catheters and noncoated nylon catheters were compared with and without the use of heparin. Carotid arteries, jugular veins, femoral arteries, and femoral veins were used. Catheters were left in place for 45 minutes. The animals were heparinized and killed. The vessels were then removed en bloc with the catheter clamped in place. The vessels were incised, and the clot was removed and weighed. In arterial and venous catheterization, no significant difference in clot deposition was shown between the hydrophilically coated catheters and the noncoated nylon catheters. A striking reduction of thrombogenicity was achieved with heparinization of the catheters in both arteries and veins. 相似文献
712.
Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors 总被引:1,自引:0,他引:1
J C Martel A Fournier S St-Pierre Y Dumont M Forest R Quirion 《Molecular pharmacology》1990,38(4):494-502
A series of fragments and analogues of neuropeptide Y (NPY), both human (hNPY) and porcine (pNPY), were synthesized and tested for their affinities at brain NPY receptor binding sites and their potencies in inhibiting the electrically stimulated twitch response of rat vas deferens. Results with N- and C-terminal fragments suggest that amino acid residues in the N-terminal portion of the molecule are mostly important for recognition of brain and vas deferens NPY receptors, in addition to being relevant for the maintenance of adequate receptor affinity. On the other hand, C-terminal amino acid residues appear to be responsible for triggering receptor activation in the rat vas deferens preparation, because full intrinsic activity is maintained with fragments up to NPY18-36. C-terminal fragment NPY25-36 and N-terminal fragment NPY1-15 were devoid of affinity for [3H]NPY brain receptor sites and showed no activity in the rat vas deferens preparation. Similarly, N-terminal fragment hNPY1-24CONH2 showed no affinity toward [3H]NPY brain receptor sites and no inhibition of the twitch response in the rat vas deferens preparation at concentrations up to 1.0 microM. On the contrary, this fragment appears to selectively increase the amplitude of the twitch response to electrical stimulation at low micromolar concentrations, an effect opposite to that of NPY and all other NPY fragments and analogues studied here. The exact mechanism mediating this contractile action of hNPY1-24CONH2 remains to be established. Modifications of the tyrosine residue in position 20 led to the development of two analogues, [D-Tyr20]hNPY and [D-Trp20]hNPY, which show an apparent preference for the vas deferens NPY receptor. On the other hand, substitutions of the tyrosine residue in position 21 by a phenylalanine ([Phe21]hNPY) or a methylated tyrosine residue ([Tyr-O-Me21]hNPY) produced analogues demonstrating an apparent preference for the brain receptor site. This suggests that modifications of tyrosine residues at positions 20 and/or 21 may eventually lead to the development of NPY analogues distinguishing between the most abundant class of sites present in the brain and vas deferens, respectively. 相似文献
713.
714.
715.
Wandering spleen--the radiological and clinical spectrum 总被引:1,自引:0,他引:1
716.
BT Bloom J Kattwinkel RT Hall PM Delmore EA Egan JR Trout MH Malloy DR Brown IR Holzman CH Coghill WA Carlo AK Pramanik MA McCaffree PL Toubas S Laudert LL Gratny KB Weatherstone JH Seguin LD Willett GR Gutcher DH Mueller WH Topper 《Pediatrics》1997,100(1):31-38
OBJECTIVE: To compare the relative safety and efficacy of Infasurf (calf lung surfactant extract; ONY, Inc, Amherst, NY, IND #27169) versus Survanta (Beractant, Ross Laboratories, Columbus, OH) in reducing the acute severity of respiratory distress syndrome (RDS) when given at birth and to infants with established RDS. DESIGN: A prospective, randomized, double-blind, multicenter clinical trial. SETTING: Thirteen neonatal intensive care units participated in the treatment arm: seven of these concurrently participated in the prevention arm. PATIENTS: The treatment arm enrolled infants of =2000 g birth weight with established RDS, and the prevention arm enrolled infants of =29 weeks' gestation with birth weights <1250 g. INTERVENTION: Infants were randomly assigned to receive Infasurf (n = 303, treatment arm; n = 180, prevention arm) or Survanta (n = 305, treatment arm; n = 194, prevention arm) in accordance with the Survanta package insert instructions. OUTCOME MEASURES: We projected a 25% reduction between groups in the need for a third dose of surfactant for infants with established RDS, and a 25% reduction in the need for a second dose of surfactant for infants who received prophylactic surfactant. Secondary outcomes included the severity of RDS measured by inspired oxygen concentrations and mean airway pressure, air leaks, complications associated with surfactant administration, and survival to 36 weeks' postmenstrual age without the need for oxygen supplementation. RESULTS: In the treatment arm, there was no difference between groups in the number of infants requiring more than two doses of surfactant. The interval between doses was significantly longer for Infasurf, suggesting an increased duration of treatment effect. The inspired oxygen concentration and mean airway pressure were lower in the Infasurf infants during the first 48 hours in the treatment arm. In the prevention arm, there were no differences with respect to the number of surfactant doses. The dosing intervals were longer for Infasurf infants after the second dose. No difference in inspired oxygen or mean airway pressure was noted during the first 72 hours. There were no significant differences in the incidence of air leaks, complications associated with dosing, complications of prematurity, mortality, or survival without chronic lung disease in the prevention or treatment arm. CONCLUSIONS: Infants treated with Infasurf have a modest benefit in the acute phase of RDS. Infasurf seems to produce a longer duration of effect than Survanta. 相似文献
717.
Wang ML; Hussey DH; Vigliotti AP; Benda J; Wen BC; Doornbos JF; Anderson B 《Radiology》1987,165(2):561-565
Between 1960 and 1979, 41 patients with adenocarcinoma of the endometrium who were poor surgical risks were treated with radiation therapy at the University of Iowa. Local tumor control was achieved in 78% of the patients, 5% manifested complications, and 46% survived 5 years ("uncorrected" 5-year survival rate). Intercurrent disease was the major cause of death (54%), and intrauterine recurrence (22%) was the most frequent recurrence. Intraperitoneal spread (12%) occurred as commonly as hematogenous metastases (12%). Three of nine local failures occurred after 5 years. Local control rates correlated well with clinical stage, and the survival rates correlated well with the stage and grade of the tumor. Local tumor control was achieved in 95% of patients who received greater than 7,000 mg-h intracavitary radium, compared with 63% of patients treated with less than 7,000 mg-h. 相似文献
718.
Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a gene causing neuronal migration defects in human brain 总被引:6,自引:2,他引:6
Ross ME; Allen KM; Srivastava AK; Featherstone T; Gleeson JG; Hirsch B; Harding BN; Andermann E; Abdullah R; Berg M; Czapansky-Bielman D; Flanders DJ; Guerrini R; Motte J; Mira AP; Scheffer I; Berkovic S; Scaravilli F; King RA; Ledbetter DH; Schlessinger D; Dobyns WB; Walsh CA 《Human molecular genetics》1997,6(4):555-562
While disorders of neuronal migration are associated with as much as 25% of
recurrent childhood seizures, few of the genes required to establish
neuronal position in cerebral cortex are known. Subcortical band
heterotopia (SBH) and lissencephaly (LIS), two distinct neuronal migration
disorders producing epilepsy and variable cognitive impairment, can be
inherited alone or together in a single pedigree. Here we report a new
genetic locus, XLIS, mapped by linkage analysis of five families and
physical mapping of a balanced X;2 translocation in a girl with LIS.
Linkage places the critical region in Xq21-q24, containing the breakpoint
that maps to Xq22.3-q23 by high-resolution chromosome analysis. Markers
used for somatic cell hybrid and fluorescence in situ hybridization
analyses place the XLIS region within a 1 cM interval. These data suggest
that SBH and X-linked lissencephaly are caused by mutation of a single
gene, XLIS, that the milder SBH phenotype in females results from random
X-inactivation (Lyonization), and that cloning of genes from the breakpoint
region on X will yield XLIS.
相似文献
719.
720.
研究泰胃关注射液在临床上常用的7种输液中的稳定性。方法:观察泰胃美注射液与7种输液配伍后外观、pH和紫外吸收度。结果:泰胃美注射液与7种输液配伍后外观、含量无明显变化。结论:泰胃美注射液可以与7种输液配伍应用。 相似文献